Harbor Advisory Corp’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.02M Sell
178,658
-3,699
-2% -$98.5K 1.51% 27
2025
Q4
$4.54M Sell
182,357
-7,567
-4% -$191K 1.37% 25
2025
Q3
$4.84M Sell
189,924
-38
-0% -$938 1.43% 25
2025
Q2
$4.6M Buy
189,962
+122,968
+184% +$2.87M 1.47% 24
2025
Q1
$1.7M Sell
66,994
-34,861
-34% -$912K 0.57% 45
2024
Q4
$2.7M Sell
101,855
-24,417
-19% -$662K 0.89% 38
2024
Q3
$3.65M Buy
126,272
+3,640
+3% +$106K 1.19% 31
2024
Q2
$3.43M Sell
122,632
-733
-0.6% -$20.2K 1.19% 32
2024
Q1
$3.42M Buy
123,365
+217
+0.2% +$6.02K 1.17% 32
2023
Q4
$3.55M Buy
123,148
+14,871
+14% +$450K 1.27% 29
2023
Q3
$3.59M Buy
108,277
+1,685
+2% +$59.6K 1.3% 29
2023
Q2
$3.91M Buy
106,592
+1,851
+2% +$72K 1.38% 25
2023
Q1
$4.27M Buy
104,741
+1,279
+1% +$55.2K 1.63% 26
2022
Q4
$5.3M Buy
103,462
+2,700
+3% +$129K 2.17% 16
2022
Q3
$4.41M Buy
100,762
+5,284
+6% +$257K 2.03% 20
2022
Q2
$5.01M Buy
95,478
+10,371
+12% +$528K 2.19% 20
2022
Q1
$4.41M Sell
85,107
-3,000
-3% -$156K 1.77% 22
2021
Q4
$5.2M Buy
88,107
+7,525
+9% +$373K 2.11% 19
2021
Q3
$3.47M Buy
80,582
+5,300
+7% +$235K 1.5% 25
2021
Q2
$2.95M Buy
+75,282
New +$2.93M 1.33% 27

Other funds holding PFE

Harbor Advisory Corp's PFE Position: Q1 2026 in Review

Harbor Advisory Corp reduced its Pfizer (PFE) stake by 2% in Q1 2026, selling an estimated $98.5K and leaving 178,658 shares worth $5.02M. The position accounts for 1.51% of the portfolio, ranked #27.

Harbor Advisory Corp first reported a position in PFE in Q2 2021 and has held it in 20 quarters since. The position peaked at $5.3M in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Harbor Advisory Corp held 178,658 shares of Pfizer worth $5.02M as of Q1 2026.
  • Harbor Advisory Corp sold 3,699 Pfizer shares in Q1 2026, an estimated $98.5K.
  • Pfizer made up 1.51% of Harbor Advisory Corp's portfolio in Q1 2026, its #27 holding.
  • Harbor Advisory Corp first reported a position in Pfizer in Q2 2021 and has held it in 20 quarters since.
  • Harbor Advisory Corp's Pfizer position peaked at $5.3M in Q4 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Harbor Advisory Corp's 13F filing for Q1 2026, filed 7 May 2026.